These results suggest that Ras activation is essential for the development of lymphoid and erythroid cells but not myeloid cells and that Ras is a critical target of BCR/ABL in the pathogenesis of CML, but not B-ALL. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.